Skip to main content
MedPathMedPath Home
Clinical Trials/NCT06544174
NCT06544174
Completed
Not Applicable

Long-term Clinical Follow up After PCI for CTO

University Hospital, Montpellier1 site in 1 country463 target enrollmentNovember 1, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCoronary Total Occlusion

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Total Occlusion
Sponsor
University Hospital, Montpellier
Enrollment
463
Locations
1
Primary Endpoint
Major cardiovascular events (MACE)
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The research aimed to evaluate the impact of a successful Percutaneous coronary intervention of chronic total occlusions (CTO-PCI) on long-term MACE (Major Cardiovascular Events), symptoms, survival, Left Ventricular Ejection Fraction (LVEF) and myocardial ischemia up-to-8-years follow-up.

Detailed Description

With this observational and prospective study, this research aimed to evaluate the impact of a successful CTO-PCI on long-term MACE (Major Cardiovascular Events), symptoms, survival, LVEF and myocardial ischemia up-to-8-years follow-up.

Registry
clinicaltrials.gov
Start Date
November 1, 2023
End Date
May 1, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •18 years or older
  • •who underwent at least one CTO procedure between 2025 and 2022 in Montpellier University Hospital
  • •symptomatic of reversible myocardial ischemia
  • •proof of myocardial viability

Exclusion Criteria

  • •refusal of the patient to participate to the study

Outcomes

Primary Outcomes

Major cardiovascular events (MACE)

Time Frame: Up to 8 years

Incidence of composite of cardiac death, non-fatal myocardial infarction and new target vessel revascularization

Secondary Outcomes

  • Non combined MACE components(Up to 8 years)
  • Restenosis(Up to 8 years)
  • LVEF(Up to 8 years)
  • In-hospital events(Up to one week)
  • Ischemic burden(Up to 8 years)
  • Stent thrombosis(Within 30 days after the procedure)

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
The Success of Opening Concurrent CTO leSion to Improve Cardiac Function Trial in Patients With Multi-vessel DiseaseChronic Total Occlusion of Coronary ArteryPercutaneous Coronary InterventionCoronary Artery DiseaseViable Myocardium
NCT03372785Beijing Anzhen Hospital240
Not yet recruiting
Not Applicable
CTO-PCI in Heart Failure PatientsCoronary Artery DiseaseChronic Total OcclusionHeart Failure
NCT05632653Universitätsmedizin Mannheim783
Completed
Not Applicable
Benefits of CTO-PCI in Selected Cases With HFrEF (CTOHFrEF)Chronic Total Occlusion Vessel
NCT02570087Hospital Clinic of Barcelona39
Completed
Not Applicable
Chronic Total Coronary Occlusion Treatment Results 6 Years After Bioresorbable Scaffold ImplantationAngina PectorisCoronary Artery DiseaseOcclusion, Coronary
NCT06164977Pauls Stradins Clinical University Hospital34
Completed
Phase 4
The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)Hibernation, MyocardialComplete Occlusion of Coronary Artery
NCT02767401The First Affiliated Hospital of Dalian Medical University200